Meramyl Hct (Hydrochlorothiazide, Ramipril)

• Meramyl Hct is used in the treatment of cardiovascular conditions that benefit from combined diuretic and ACE‑inhibitor therapy.
• Hypertension: lowers systolic and diastolic blood pressure in patients with primary hypertension.
• Heart failure: provides adjunctive blood‑pressure control and reduces fluid overload when combined with standard heart‑failure regimens.
• Post‑myocardial infarction: helps to improve long‑term cardiovascular outcomes by controlling blood pressure and reducing ventricular remodeling.

• Ramipril blocks the angiotensin‑converting enzyme, decreasing formation of angiotensin II and reducing vasoconstriction and aldosterone‑mediated sodium retention. Hydrochlorothiazide inhibits sodium‑chloride reabsorption in the distal convoluted tubule, increasing urinary excretion of water and electrolytes, which together lower peripheral vascular resistance and blood volume, resulting in reduced arterial pressure.

Common Side Effects

• Dizziness or light‑headedness, especially after the first dose.
• Persistent dry cough.
• Increased frequency of urination.
• Mild headache.
• Electrolyte disturbances such as low potassium or sodium.
• Fatigue or general weakness.

Serious or Rare Side Effects

• Angioedema or severe swelling of the face, lips, tongue, or throat.
• Anaphylactic reactions.
• Severe dehydration or electrolyte imbalance.
• Acute kidney injury or worsening renal function.
• Hyperkalemia leading to cardiac arrhythmia.
• Severe hypotension causing fainting or shock.

Before initiating therapy, clinicians should assess patient history and monitor relevant parameters.

• Blood pressure monitoring: ensure target levels are achieved without excessive drop.
• Renal function: check serum creatinine and eGFR periodically.
• Electrolyte balance: monitor potassium and sodium levels, especially in patients on other diuretics.
• Hypersensitivity: avoid in individuals with known allergy to ACE inhibitors or thiazide diuretics.
• Elderly patients: start at lower dose and monitor for orthostatic hypotension.

Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

When prescribing Meramyl Hct, consider potential drug‑drug interactions.

Major Interactions (Avoid)

• Aliskiren in patients with diabetes or renal impairment.
• Potassium‑sparing diuretics or supplements (risk of hyperkalemia).
• NSAIDs (may blunt antihypertensive effect and impair renal function).
• Lithium (increased lithium levels and toxicity).
• Concurrent use of another ACE inhibitor or ARB (excessive renin‑angiotensin blockade).

Moderate Interactions (Monitor Closely)

• Other antihypertensives (additive blood‑pressure lowering, monitor for hypotension).
• Digoxin (diuretics may alter serum digoxin levels).
• Antidiabetic agents (diuretic‑induced changes in glucose control).
• Corticosteroids (may increase fluid retention).
• Loop diuretics (enhanced electrolyte disturbances).